Stromal cell derived factor-1alpha protects stem cell derived insulin-producing cells from glucotoxicity under high glucose conditions in-vitro and ameliorates drug induced diabetes in rats

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Tariq, Muhammad ^a,b   Masoud, Muhammad Sharif ^a,c   Mehmood, Azra ^a   Khan, Shaheen N ^a   Riazuddin, Sheikh ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b MIRPUR UNIVERSITY OF SCIENCE AND TECHNOLOGY MUST   (Pakistan)

^c GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Diabetes mellitus; Differentiation; Mesenchymal stem cells; Preconditioning; SDF 1

Indexed keywords

GLUCOSE; INSULIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOTOXICITY; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN PRODUCING CELL; INSULIN RELEASE; MESENCHYMAL STEM CELL; NONHUMAN; RAT; STEM CELL;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CXCL12; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; FEMALE; GLUCOSE; INSULIN; KI-67 ANTIGEN; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 84877063730     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-115     Document Type: Article

References (46)

1. Gepts W. Islet morphology in type 1 diabetes. Behring Inst Mitt 1984, 75:39-41.
2. Shaw JE, Sicree RA, Zimment Global estimates of the prevalence of diabetes for 2110 and 2030. Diabetes Res Clin Pract 2010, 87:4-14. 10.1016/j.diabres.2009.10.007, 19896746, Zimment.
3. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas and islet transplantation in type 1 diabetes. Diabetes Care 2006, 29(4):935.
4. Marzorati S, Pileggi A, Ricordi C. Allogeneic islet transplantation. Expert Opin Biol Ther 2007, 7(11):1627-1645. 10.1517/14712598.7.11.1627, 17961088.
5. Bianco P, Kuznetsov SA, Riminucci M, Gehron RP. Postnatal skeletal stem cells. Methods Enzymol 2006, 419:117-148.
6. Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M. Concise review: Mesenchymal stem cell treatment of the complications of diabetes. Stem Cells 2011, 29(1):5-10. 10.1002/stem.556, 3059410, 21280154.
7. Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 2010, 43:255-263. 10.3109/08916930903305641, 19845478.
8. Xie QP, Huang H, Xu B, Dong X, Gao SL, Zhang B, Wu YL. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation 2009, 77:483-491. 10.1016/j.diff.2009.01.001, 19505629.
9. Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H, Wang KX. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J 2007, 120:771-776.
10. Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, Bosco D, Favrot M, Benhamou PY. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005, 23(4):594-603. 10.1634/stemcells.2004-0123, 15790780.
11. Zanini C, Bruno S, Mandili G, Baci D, Cerutti F, Cenacchi G, Izzi L, Camussi G, Forni M. Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype. PLoS One 2011, 6(12):e28175. 10.1371/journal.pone.0028175, 3241623, 22194812.
12. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 2004, 10(20):3016-3020.
13. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007, 25:371-379. 10.1634/stemcells.2005-0620, 17038675.
14. Le Blanc K, Pittenger M. Mesenchymal stem cells: Progress toward promise. Cytotherapy 2005, 7:36-45.
15. Atsma DE, Fibbe WE, Rabelink TJ. Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol 2007, 18:645-649. 10.1097/MOL.0b013e3282f0dd1f, 17993810.
16. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414:821-827. 10.1038/414821a, 11742415.
17. Micallef SJ, Janes ME, Knezevic K, Davis RP, Elefanty AG, Stanley EG. Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. Diabetes 2005, 54:301-305.
18. Shi Y, Hou L, Tang F, Jiang W, Wang P, Ding M, Deng H. Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 2005, 23(5):656-662. 10.1634/stemcells.2004-0241, 15849173.
19. Otonkoski T, Beattie GM, Mally MI, Ricordi C, Hayek A. Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest 1993, 92(3):1459-1466. 10.1172/JCI116723, 288291, 8104197.
20. Edlund H. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat Rev Genet 2002, 3:524-532. 10.1038/nrg841, 12094230.
21. Egan JM, Bulotta A, Hui H, Perfetti R. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metab Res Rev 2003, 19:115-123. 10.1002/dmrr.357, 12673779.
22. Yano N, Suzuki D, Endoh M, Zhao CT, Padbury JF, Tseng YT. A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells. J Biol Chem 2007, 282:18819. 10.1074/jbc.M610537200, 17493931.
23. Peng H, Huang Y, Rose J, Erichsen D, Herek S, Fujii N, Tamamura H, Zheng J. Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J Neurosci Res 2004, 76(1):35-50. 10.1002/jnr.20045, 15048928.
24. Kayali AG, Van Gunst K, Campbell IL, Stotland A, Kritzik M, Liu G, Flodstrom-Tullberg M, Zhang YQ, Sarvetnick N. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 2003, 163:859-869. 10.1083/jcb.200304153, 2173676, 14638861.
25. Yao R, Cooper GM. Requirement for phosphatidylinosotol- 3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995, 267:2003-2006. 10.1126/science.7701324, 7701324.
26. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999, 13:2905-2927. 10.1101/gad.13.22.2905, 10579998.
27. Jetton TL, Lausier J, LaRock K, Trotman WE, Larmie B, Habibovic A, Peshavaria M, Leahy JL. Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 2005, 54(8):2294-2304. 10.2337/diabetes.54.8.2294, 16046294.
28. Watanabe H, Saito H, Rychahou PG, Uchida T, Evers BM. Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3 kinase/Aktactivation. Gastroenterology 2005, 128:1391-1404. 10.1053/j.gastro.2005.03.016, 15887120.
29. Rakienten N, Rakienten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin. Cancer Chemotheraphy Reports 1963, 29:91-98.
30. Pasha Z, Wang Y, Sheikh R, Zhang Z, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008, 77:134-142.
31. Wu XH, Liu CP, Xu KF, Mao XD, Zhu J, Jiang JJ, Cui D, Zhang M, Xu Y, Liu C. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol 2007, 13(24):3342-3349.
32. Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, Atkinson MA, Yang MJ. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004, 53:1721-1732. 10.2337/diabetes.53.7.1721, 3422216, 15220196.
33. Li L, Yi M, Seno M, Kojima I. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 2004, 53:608-615. 10.2337/diabetes.53.3.608, 14988244.
34. Suzuki A, Nakauchi H, Taniguchi H. Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA 2003, 100(9):5034-5039. 10.1073/pnas.0936260100, 154293, 12702762.
35. Tayaramma T, Ma B, Rohde M, Mayer H. Chromatin remodeling factors allow differentiation of bone marrow cells into insulin-producing cells. Stem Cells 2006, 24:2858-2867. 10.1634/stemcells.2006-0109, 16990588.
36. Neshati Z, Matin MM, Bahrami AR, Moghimi A. Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats. J Physiol Biochem 2010, 66(2):181-187. 10.1007/s13105-010-0013-y, 20422338.
37. Chakrabarti SK, Mirmira RG. Transcription factors direct the development and function of pancreatic β cells. Trends Endocrinol Metab 2003, 2:78-84.
38. Sumi S, Gu Y, Hiura A, Inoue K. Stem cells and regenerative medicine for diabetes mellitus. Pancreas 2004, 29:e85-e89. 10.1097/00006676-200410000-00017, 15367898.
39. Henseleit KD, Nelson SB, Kuhlbrodt K, Hennings JC, Ericson J, Sander M. NKX6 transcription factor activity is required for β- and β-cell development in the pancreas. Development 2005, 132:3139-3149. 10.1242/dev.01875, 15944193.
40. Oliver-Krasinski JM, Stoffers DA. On the origin of the β-cell. Genes Dev 2008, 22:1998-2021. 10.1101/gad.1670808, 2735346, 18676806.
41. Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005, 146:1025-1034.
42. Kume S. Stem-cell-based approaches for regenerative medicine. Dev Growth Differ 2005, 47(6):393-402. 10.1111/j.1440-169X.2005.00814.x, 16109037.
43. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000, 97:1607-1611. 10.1073/pnas.97.4.1607, 26482, 10677506.
44. Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L, Zhang L, Huang Y. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 2009, 36:644-650. 10.1016/j.ejcts.2009.04.052, 19524448.
45. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28:299-307. 10.1016/j.it.2007.05.007, 2952492, 17560169.
46. Masoud MS, Anwar SS, Afzal MZ, Mehmood A, Khan SN, Riazuddin S. Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment. J Transl Med 2012, 5(10):243.